» Articles » PMID: 16406726

High Throughput DNA Sequence Variant Detection by Conformation Sensitive Capillary Electrophoresis and Automated Peak Comparison

Abstract

We report the development of a heteroduplex-based mutation detection method using multicapillary automated sequencers, known as conformation-sensitive capillary electrophoresis (CSCE). Our optimized CSCE protocol detected 93 of 95 known base substitution sequence variants. Since the optimization of the method, we have analyzed 215 Mb of DNA and identified 3397 unique variants. An analysis of this data set indicates that the sensitivity of CSCE is above 95% in the central 56% of the average PCR product. To fully exploit the mutation detection capacity of this method, we have developed software, canplot, which automatically compares normal and test results to prioritize samples that are most likely to contain variants. Using multiple fluorescent dyes, CSCE has the capacity to screen over 2.2 Mb on one ABI3730 each day. Therefore this technique is suitable for projects where a rapid and sensitive DNA mutation detection system is required.

Citing Articles

Endonuclease-based genotyping of the RBM as a method to track the emergence or evolution of SARS-CoV-2 variants.

Lopez E, Barthelemy M, Baronti C, Masse S, Falchi A, Durbesson F iScience. 2021; 24(11):103329.

PMID: 34697603 PMC: 8529542. DOI: 10.1016/j.isci.2021.103329.


Discriminant Analysis of Lung Cancer Using Nonlinear Clustering of Copy Numbers.

N Kachouie N, Shutaywi M, Christiani D Cancer Invest. 2020; 38(2):102-112.

PMID: 31977287 PMC: 10283398. DOI: 10.1080/07357907.2020.1719501.


Detection of Local DNA Copy Number Changes in Lung Cancer Population Analyses Using A Multi-Scale Approach.

N Kachouie N, Lin X, Christiani D, Schwartzman A Commun Stat Case Stud Data Anal Appl. 2019; 1(4):206-216.

PMID: 31489360 PMC: 6727850. DOI: 10.1080/23737484.2016.1197079.


Prevalence of germline TP53 mutations in HER2+ breast cancer patients.

Rath M, Masciari S, Gelman R, Miron A, Miron P, Foley K Breast Cancer Res Treat. 2013; 139(1):193-8.

PMID: 23580068 PMC: 4280061. DOI: 10.1007/s10549-012-2375-z.


Activating BRAF gene mutations are uncommon in hormone refractory prostate cancer in Caucasian patients.

Kollermann J, Albrecht H, Schlomm T, Huland H, Graefen M, Bokemeyer C Oncol Lett. 2012; 1(4):729-732.

PMID: 22966370 PMC: 3436437. DOI: 10.3892/ol_00000127.